Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2020 Jun 18;15(6):e0234956. doi: 10.1371/journal.pone.0234956

Involuntary ambulatory triage during the COVID-19 pandemic – A neurosurgical perspective

Harald Krenzlin 1,*, Christoph Bettag 2, Veit Rohde 2, Florian Ringel 1, Naureen Keric 1
Editor: Itamar Ashkenazi3
PMCID: PMC7302699  PMID: 32555723

Abstract

Background

The coronavirus disease 2019 (COVID-19) pandemic poses an unprecedented challenge to health-care systems around the world. As approximately one-third of the world´s population is living under “lockdown” conditions, medical resources are being reallocated and hospital admissions are limited to emergencies. We examined the decision-making impact of these actions and their effects on access to hospital treatment in patients with neurosurgical conditions.

Methods

This retrospective cohort study analyzes hospital admissions of two major neurosurgical services in Germany during the nationwide lockdown period (March 16th to April 16th, 2020). Spinal or cranial conditions requiring immediate hospital admission and treatment constituted emergencies.

Results

A total of 243 in-patients were treated between March 16th and April 16th 2020 (122 patients at the University Medical Center Mainz, 121 patients at the University Medical Center Göttingen). Of these, 38.0±16% qualified as emergency admission. Another 1,688 admissions were reviewed during the same periods in 2018 and 2019, providing a frame of reference. Overall, emergency admissions declined by 44.7±0.7% during lockdown. Admissions for cranial emergencies fell by 48.1±4.44%, spinal emergencies by 30.9±14.6%.

Conclusion

Above findings indicate that in addition to postponing elective procedures, emergency admissions were dramatically curtailed during the COVID-19 lockdown. As this surely is unexpected and unintended, reasons are undoubtedly complex. As consequences in morbidity and mortality are still unpredictable, efforts should be made to accommodate all patients in need of hospital access going forward.

Introduction

At the beginning of 2020, a novel Coronavirus (2019-nCoV) contagion had spread to 18 countries, four of them reporting human-to-human transmission. The World Health Organization (WHO) subsequently declared the outbreak a Public Health Emergency of International Concern (PHEIC) on January 30. The first cases of respiratory infections due to 2019-nCoV were reported on December 31, 2019, occurring in China’s Hubei province. [1]

Similarity to the severe airway respiratory syndrome (SARS) prompted a later change in nomenclature from 2019-nCoV to SARS-CoV-2. [2] Meanwhile, the growing coronavirus disease 2019 (COVID-19) pandemic had presented a new and unprecedented challenge to our healthcare system. [3] Hospitals and intensive care units are near breaking points in dealing with those suffering from this infection, forcing lockdown conditions on one-third of the world´s population. [4] As of April 19th, 2020, nearly 2 million people had been infected worldwide. In Germany the number of confirmed cases had risen to 145,742 with 4,642 deceased.

Aside from guidelines issued by the WHO, each country was separately tasked with handling the SARS-CoV-2 viral threat. In Germany, the chief governmental scientific institute in the field of biomedicine and the most important body for safeguarding public health is the Robert Koch-Institute (RKI). Its pandemic plan, which was revised and then amended in March 2020, offers specific protocols for addressing situations like the current SARS-CoV-2 outbreak. The strategy to deal with evolving epidemiological phases is marked by three fluid levels of escalation: containment, protection, and mitigation. We are currently at the point of pandemic mitigation, having enacted a nationwide lockdown on March 16, 2020. This included social distancing, curfews, and a ban on public assembly, with the closure of shops, schools and childcare. A televised address by Chancellor Angela Merkel was delivered 2 days thereafter to reinforce these measures.

To prevent a healthcare system overload, such as that occurring in Italy, hospitals hurriedly adapted to the state of pandemic. The German Hospital Federation, in collaboration with other hospital-related federal organizations and representatives of larger medical centers, agreed to increase ventilator and intensive care capacities. At the same time, nursing staff medical and medical assistants were duly instructed and reallocated to offset expected increases in patients stricken with COVID-19. A unified decision to halt elective hospital admissions and postpone non-emergency surgeries made this historic restructuring possible. The task of triage was assigned to medical personal at all tiers of the German healthcare system. As neurosurgical procedures have declined, however, the ramifications of these policies on pertinent decision- making and inpatient treatment access remain unclear.

This study was conducted to analyze likely impediments to receipt of adequate neurosurgical treatment during the COVID-19 pandemic.

Methods

Patient population

All admissions to the Department of Neurosurgery, University Medical Center Mainz between January 1st to April 19th, 2018–2020 were reviewed for this study. Admission type (elective vs. emergency) and means (transfer from outside hospital, in- hospital transfer, emergency room visit, or referral) were recorded.

The time span beginning March 16th to April 19th, 2020 was defined as core lockdown period. Emergency admissions and means (transfer from outside hospital, in- hospital transfer, emergency room visit, or referral) during this time were assessed and compared with the same timeframe in 2018 and 2019. Two major neurosurgical departments in Germany; The Department of Neurosurgery at the University Medical Center of the Johannes Gutenberg University Mainz and The Department of Neurosurgery at the University Hospital of the Georg August University Göttingen contributed to this analysis.

Emergencies

Emergencies were defined as those requiring immediate or timely access and treatment within 1–2 days. Each was then categorized by admitting diagnosis as either cranial or spinal emergency. Cranial emergencies were further stratified as vascular, tumor-related, traumatic or infectious and miscellaneous; designating spinal emergencies as traumatic, tumor-related, degenerative or infectious.

Statistical analysis

All clinical parameters were collected and analyzed retrospectively. Data acquisition and analysis proceeded in anonymous fashion and is expressed as mean ± standard deviation (SD). Student’s T-test (two tailed) and two-way analysis of variance (ANOVA) with Tukey’s multiple comparison post hoc test were performed using GraphPad Prism version 8.4.2 for macOS, GraphPad Software, La Jolla California USA, www.graphpad.com. A value of P < 0.05 was accepted as statistically significant.

Ethical approval

Data acquisition and analysis was performed in an anonymous fashion and was approved by the Ethics Committees of the medical association of Rhineland Palatinate and Lower Saxony, Germany. According to the local laws, no informed consent is necessary for such kind of analysis.

Results

From January 1st to April 19th, 2020, a total of 822 patients were admitted to the Department of Neurosurgery, University Medical Center Mainz. Mean patient age was 57.7±16.9 (range 16–96 years), similar numbers were recorded in 2018 and 2019 (2018: 856 patients, 57,4±17.6 years; 2019: 968 patients, 59,6±17.0 years). A total of 101 emergency admissions (spinal: 28; cranial: 73) took place as emergency during March 2020. In the 2 weeks prior to lockdown, there were 66 emergency admissions (spinal: 17; cranial: 49). During the first 2 weeks of lockdown, emergency admissions sharply declined to 30 (cranial: 24, spinal 11) and remained low, totaling 38 (cranial: 28, spinal: 10) throughout the beginning of April. Overall emergency admissions dropped by 47% (cranial: 51%, spinal: 35.3%) during the first 2 weeks of lockdown and by 62.1% (cranial: 63.3%, spinal 58.8%) during weeks 3 to 4. (Fig 1). Vascular emergencies showed the steepest decline (81.8%), followed by admission for trauma (53.3%) (Fig 1). Patient routes leading to hospital admission likewise changed during the COVID-19 pandemic. Referrals, hospital transfers and visits to the emergency department all declined during the first 2 weeks of shut down and even further through week 3 to 4. (Fig 1)

Fig 1. Emergency admissions to the Department of Neurosurgery at the University Medical Center Mainz 2 weeks before and during the nationwide lockdown.

Fig 1

A) Admissions for spinal and cranial emergencies. B) Distribution of cranial emergencies. C) Patient routes leading to hospital admission during the COVID-19 pandemic.

A 5-weeks period between March 16th to April 19th, 2020 constituted the core lockdown phase. Emergency admissions at both departments declined by 44.7±0.7% (cranial: 48.1±4.44%, spinal 30.9±14.6%) compared to 2018 and 2019 (p < .05) (Fig 2).

Fig 2. Combined emergency admissions to the Departments of Neurosurgery of the University Medical Centers Mainz and Göttingen during lockdown compared to 2018/2019.

Fig 2

Combined, admissions due to brain tumors declined by 61.1±38.8%, those for traumatic brain injury by 53.8±0.6% and those for 42.0±39.%. Both hospitals saw the highest decline of admissions via the emergency department 53.1±5.7%. Emergency transfers from smaller hospitals remained unchanged, going down by 3.2±7.9% compared to previous years.

During the lockdown period, the ICU bed capacity, availability of personal protective equipment (PPE) and manpower for the treatment of COVID-19 patients has never been fully exploited through treating those admitted with SARS-CoV2 infection in both Medical Centers.

Discussion

The present analysis indicates that in addition to postponing elective procedures during the COVID-19 crisis, emergency admission dramatically declined. To our knowledge, this is the first documentation of the impact made by consecutive epidemiological countermeasures enacted for non COVID-19 emergency admissions to hospitals in Germany during the SARS-CoV-2 pandemic.

The reservations carried by the general public against hospital visits during the pandemic are reflected by plummeting numbers of visits to the emergency department. Our observations are aligned with reported analogous declines of patient admissions in Italy for minor strokes and transient ischemic attacks during the pandemic spread. [4] Moreover, patient arrivals were increasingly too late to initiate acute stroke treatment, causing reporting rates of thrombolysis and combined thrombolysis-thrombectomy to decline. [5] So far, it is unknown what kept people away from hospitals and if this tendency was more pronounced in larger medical centers. One reason might be the overall attempt to avoid exposition to patients with SARS-CoV2 infection perceived as unnecessary by avoiding hospitals and doctor consultations in situation, where such would have been commonplace previous to the pandemic. In turn, this refusal might lead to protracted hospital admissions or an increase of prehospital mortality. Countries participating in EuroMOMO (European mortality monitoring activity; https://www.euromomo.eu/) reported high above average excess death rates coinciding with the SARS-CoV2 pandemic. As the excess mortality only partially reflects the COVID-19 case fatality, delayed hospital admission might be a contributing factor. Measures taken to mitigate the risk of viral spreading such as social distancing and refrain from visiting the elderly lead to delays in detection of situations where those who we aim to protect from infection are unable to obtain the help they require due to conditions other than COVID-19. As in Italy, the prevailing inclination of Germans overall and among primary care physicians in particular was to avoid admitting elderly patients or those with multiple comorbidities or cancer. [6] The tenets of COVID-19 risk profiling are unfortunately often shared by patients admitted for neurosurgical vascular or spinal emergencies. In the absence of reasonable explanations why the incidence of malignancies or vascular incidents should decline during a viral pandemic, it seems that patients in need of neurosurgical care are either admitted delayed or not at all during this difficult time. It remains to be seen whether the decline of admissions for traumatic brain injury is rather caused by a lower incidence due to restricted mobility or an epiphenomenon of social distancing leading to isolation and unobserved accidents with a higher pre-hospital cases fatality. Additionally, delays in diagnosis and treatment of non-life-threatening conditions might lead to an increased morbidity burden in the month to come.

As a result, transparency in communication and avoidance of unnecessary ambiguity on the state of our hospitals and the feasibility of emergency treatment is utmost important. It is therefore of exceptional importance to minimize errors in obligatory patient prioritization during the COVID-19 pandemic. [7] In a joint effort the German Society of Neurosurgery (DGNC) and the Professional Association of German Neurosurgeons (BDNC) thus jointly drafted a paper delimiting all non-elective surgical interventions in their purview (https://www.dgnc.de/fileadmin/media/dgnc_homepage/publikationen/downloads/DGNC_BDNC_non-elective_surgical_interventions.pdf) to rectify the situation. Ultimately, any underlying condition (cancer, organ failure, vascular disease, secondary complications of a disease or accident) that may inflict irreversible harm if prolonged qualifies as a time-sensitive vulnerability and should still be considered for immediate treatment, despite the ongoing pandemic. [8] Additionally, patients with cancer are at higher risk of COVID-19 infection and have poorer outcomes than the general population. [9] In cases of emergency, the results of COVID-19 testing may not be available prior to surgery so that particular precautions to minimize possible exposure to the novel coronavirus during the procedures are mandatory. [10] During times of unprecedented strain on our healthcare system, an attempt to balance the acuity of medical needs with available resources is of overarching importance. [8, 11] It is noteworthy that none of the cases primarily postponed as elective surgical interventions re-presented as emergencies during the course of the lockdown period. This circumstance merits the early and careful consideration put into the delimiting of non-elective surgical interventions. Nevertheless,cancelling elective surgeries reinforced the feeling of insecurity in patients already burdened with steep social changes. Telephone consultations increased during the time of lockdown hinting at a general lack of information about the enforced changes to the healthcare system.

In retrospect, the capacity to treat patients with COVID-19 has never been fully tested by the actual number of admissions. Thus, in addition to declining numbers of emergency cases led to a reduced utilization of hospital resources. Those resources could have been put to good use treating those who refrained from presenting to a hospital due to fear infection and lack of information regarding the COVID-19 situation in our healthcare system.

From an epidemiological point of view, experience with a pandemic of this magnitude is scarce. Based on the assumption that hospital admissions decline despite constant incidence of certain diseases (e.g. brain tumors) an accumulation of cases leading to higher numbers of hospital admissions in the wake of the pandemic are to be expected. Thus, our healthcare system is not only obliged to accommodate enough resources to counter COVID-19 but to be prepared to provide for more than the average share of cases once the pandemic subsides.

Conclusion

During the present pandemic, it is the incumbent upon all healthcare providers to foster awareness in the neediest of patients, so that essential treatment may be rendered expeditiously, without pointless or harmful delays.

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395(10223):514–23. Epub 2020/01/28. 10.1016/S0140-6736(20)30154-9 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, Evaluation and Treatment Coronavirus (COVID-19). StatPearls; Treasure Island (FL)2020. [PubMed] [Google Scholar]
  • 3.Khosravani H, Rajendram P, Notario L, Chapman MG, Menon BK. Protected Code Stroke: Hyperacute Stroke Management During the Coronavirus Disease 2019 (COVID-19) Pandemic. Stroke. 2020:STROKEAHA120029838. Epub 2020/04/03. 10.1161/STROKEAHA.120.029838 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Caso V, Federico A. No lockdown for neurological diseases during COVID19 pandemic infection. Neurol Sci. 2020. Epub 2020/04/10. 10.1007/s10072-020-04389-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Baracchini C, Pieroni A, Viaro F, Cianci V, Cattelan AM, Tiberio I, et al. Acute stroke management pathway during Coronavirus-19 pandemic. Neurol Sci. 2020. Epub 2020/04/10. 10.1007/s10072-020-04375-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Group C-S. Characteristics of COVID-19 patients dying in ItalyReport based on available data on March 26th, 2020: Istituto Superiore di Sanità; 2020. [Google Scholar]
  • 7.Kim SYH, Grady C. Ethics in the time of COVID: What remains the same and what is different. Neurology. 2020. Epub 2020/04/08. 10.1212/WNL.0000000000009520 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Ramakrishna R, Zadeh G, Sheehan JP, Aghi MK. Inpatient and outpatient case prioritization for patients with neuro-oncologic disease amid the COVID-19 pandemic: general guidance for neuro-oncology practitioners from the AANS/CNS Tumor Section and Society for Neuro-Oncology. J Neurooncol. 2020. Epub 2020/04/11. 10.1007/s11060-020-03488-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335–7. Epub 2020/02/19. 10.1016/S1470-2045(20)30096-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Hu YJ, Zhang JM, Chen ZP. Experiences of practicing surgical neuro-oncology during the COVID-19 pandemic. J Neurooncol. 2020. Epub 2020/04/12. 10.1007/s11060-020-03489-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Mohile NA, Blakeley JO, Gatson NTN, Hottinger AF, Lassman AB, Ney DE, et al. Urgent Considerations for the Neuro-oncologic Treatment of Patients with Gliomas During the COVID-19 Pandemic. Neuro Oncol. 2020. Epub 2020/04/12. 10.1093/neuonc/noaa090 . [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Itamar Ashkenazi

25 May 2020

PONE-D-20-12668

Involuntary ambulatory triage during the COVID-19 pandemic – a neurosurgical perspective

PLOS ONE

Dear Dr. Krenzlin,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jul 09 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Itamar Ashkenazi

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. In the ethics statement in the manuscript and in the online submission form, please provide additional information about the patient records used in your retrospective study, including: a) the date range (month and year) during which the medical records of patients who visited the medical center in Gottingen were reivewed; and b) the source of the medical records analyzed in this work (e.g. the full name of the medical center in Gottingen).

3. To comply with PLOS ONE submission guidelines, in your Methods section, please provide additional information regarding your statistical analyses. For more information on PLOS ONE's expectations for statistical reporting, please see https://journals.plos.org/plosone/s/submission-guidelines.#loc-statistical-reporting.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors evaluated the impact of the COVID 19 pandemic on admission from Jan 1st to April 19 2020 and compared to previous years. They found significant decline in the emergency admission rate during the timing of lock down.

The authors discussed the decline in all aspect of neurosurgery seen. The impact of this decline was not discussed as the authors discussed they do not have the time.

Additionally there is no mention on whether the reduced admission significantly impacted the overall availability of ICU beds, PPE and man power for treatment of COVID 19 patients.

Given the reduction in pathology that would most likely utilized the most healthcare system such as trauma, is there a balance that can be had?

What is the impact on the patient's whose elective surgery were cancelled,

were any patient who was admitted emergently a patient who was previously thought to be an elective case?

Reviewer #2: This manuscript provides an important snapshot into the impact Covid has made on patient care. One minor revision- recommend reword "attempt to evade exposition to patients " to avoid exposure in the discussion.

Reviewer #3: This is useful and very topical study on decline of neurosurgical admission in time of COVID pandemic. Subject is very important in aplanning how to finish selective 'lockdown' policy in hospitals.

We found it topical and very useful

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Kingsley Abode-Iyamah

Reviewer #2: No

Reviewer #3: Yes: Marek Czosnyka

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2020 Jun 18;15(6):e0234956. doi: 10.1371/journal.pone.0234956.r002

Author response to Decision Letter 0


1 Jun 2020

Response to the reviewers

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

-> The manuscript has been revised to adhere to the style requirements of PLOS one.

2. In the ethics statement in the manuscript and in the online submission form, please provide additional information about the patient records used in your retrospective study, including: a) the date range (month and year) during which the medical records of patients who visited the medical center in Gottingen were reivewed; and b) the source of the medical records analyzed in this work (e.g. the full name of the medical center in Gottingen).

-> The methods/patient population section has been amended addressing the participating hospitals properly as The Department of Neurosurgery at the University Medical Center of the Johannes Gutenberg University Mainz and The Department of Neurosurgery at the University Hospital of the Georg August University Göttingen.

-> The date range (month and year) during which the medical records of patients who visited the medical center in Gottingen were reivewed has been update within the same section.

3. To comply with PLOS ONE submission guidelines, in your Methods section, please provide additional information regarding your statistical analyses. For more information on PLOS ONE's expectations for statistical reporting, please see https://journals.plos.org/plosone/s/submission-guidelines.#loc-statistical-reporting.

-> GraphPad Prism is now cited in the statistical analysis section. Further, Tukey’s multiple comparison has been detailed as post hoc test. The used T-test is now specified to comply with PLOS ONE's expectations for statistical reporting.

Reviewer #1: The authors evaluated the impact of the COVID 19 pandemic on admission from Jan 1st to April 19 2020 and compared to previous years. They found significant decline in the emergency admission rate during the timing of lock down.

1. The authors discussed the decline in all aspect of neurosurgery seen. The impact of this decline was not discussed as the authors discussed they do not have the time.

-> Emergency admissions dramatically declined during the nationwide lockdown period. Patients in need of neurosurgical care were admitted delayed or not at all. The overall death rate from March to May, 2020 in Germany is higher than the average of three consecutive years before. It is also higher than the COVID-19 associated mortality and thus hints at the impact of declining hospital admissions. A section discussing the impact of the declining hospital admissions together with the European mortality monitoring activity on average death rates has been added to the discussion section.

2. Additionally there is no mention on whether the reduced admission significantly impacted the overall availability of ICU beds, PPE and man power for treatment of COVID 19 patients.

-> A passage has been included under results stating that the capacity for treatment of COVID 19 patients has never been tested by the number of admitted cases.

3. Given the reduction in pathology that would most likely utilized the most healthcare system such as trauma, is there a balance that can be had?

-> A new passage has been added to the discussion section explaining the ambiguity of additional ICU capacity, spare work force on one hand and fewer numbers of COVID 19 patients and reduced numbers of emergency admissions other than COVID19 (EAOC19 :) on the other.

4. What is the impact on the patient's whose elective surgery were cancelled,

-> Cancelling elective surgeries reinforced the feeling of insecurity in our patients already burdened with steep social changes. Telephone consultations increased during the time of lockdown hinting at a general lack of information about the changes to our healthcare system. This line of thought has also been added to the discussion section of our manuscript.

5. Were any patient who was admitted emergently a patient who was previously thought to be an elective case?

-> Interestingly, our hospitals have not seen elective surgical interventions presenting as emergencies during the lockdown period. This might partially be due to the careful considerations put into the delimiting of non-elective surgical interventions by the German Society of Neurosurgery (DGNC) and the Professional Association of German Neurosurgeons (BDNC). This circumstance has now been to the discussion section of our manuscript.

Reviewer #2: This manuscript provides an important snapshot into the impact Covid has made on patient care.

1. One minor revision- recommend reword "attempt to evade exposition to patients " to avoid exposure in the discussion.

-> The wording has been changed accordingly.

Reviewer #3: This is useful and very topical study on decline of neurosurgical admission in time of COVID pandemic. Subject is very important in aplanning how to finish selective 'lockdown' policy in hospitals. We found it topical and very useful

-> We are honored by the appreciation and endorsement of our manuscript.

2. While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: Response to reviewers.docx

Decision Letter 1

Itamar Ashkenazi

8 Jun 2020

Involuntary ambulatory triage during the COVID-19 pandemic – a neurosurgical perspective

PONE-D-20-12668R1

Dear Dr. Krenzlin,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Itamar Ashkenazi

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Itamar Ashkenazi

10 Jun 2020

PONE-D-20-12668R1

Involuntary ambulatory triage during the COVID-19 pandemic – a neurosurgical perspective

Dear Dr. Krenzlin:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Itamar Ashkenazi

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: Response to reviewers.docx

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES